Clinical Trial Update: Endoscopic Cyanoacrylate Obliteration vs. Nadolol Treatment in the Prevention of Gastric Variceal Rebleeding [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing endoscopic cyanoacrylate obliteration to nadolol for preventing gastric variceal rebleeding in patients with liver cirrhosis; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Variceal Bleeding
• Hepatocellular Carcinoma
• Liver Cirrhosis

Drugs mentioned

• Histoacryl (N-butyl-2-cyanoacrylate) (N-butyl-2-cyanoacrylate)
• Nadolol (Nadolol)

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Liver Cirrhosis and Hepatoma., Gastric Variceal Bleeding | Phase 4 | Status: UNKNOWN